• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2025
  • Select Year
    1. 2025
    2. 2024
    3. 2023
    4. 2022
    5. 2021
    6. 2020
    7. 2019
    8. 2018
    9. 2017
    10. 2016
    11. 2015
    12. 2014
    13. 2013
    14. 2012
    15. 2011
    16. 2010
    17. 2009
    18. 2008
    19. 2007
  • 06.05.2025

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April, 2025

  • 30.04.2025

    Circulars - [Other] Notification Letter

  • 30.04.2025

    Circulars - [Other] Notification Letter

  • 30.04.2025

    Proxy Forms Proxy form for use at the annual general meeting (the "AGM") of Tianda Pharmaceuticals Limited to be held on Friday, 13 June 2025 at 10:30 a.m. (or at any adjournment thereof)

  • 30.04.2025

    Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING

  • 30.04.2025

    Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval] PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING

  • 02.04.2025

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March, 2025

  • 28.03.2025

    Announcements and Notices - [Final Results] FINAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024

  • 25.03.2025

    Announcements and Notices - [Profit Warning / Inside Information] PROFIT WARNING

  • 18.03.2025

    Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING

  • 03.03.2025

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February, 2025

  • 05.02.2025

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January, 2025

  • 02.01.2025

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December, 2024

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice